Filter Results
:
(695)
Show Results For
-
All HBS Web
(695)
- People (1)
- News (252)
- Research (348)
- Events (13)
- Multimedia (14)
- Faculty Publications (132)
Show Results For
-
All HBS Web
(695)
- People (1)
- News (252)
- Research (348)
- Events (13)
- Multimedia (14)
- Faculty Publications (132)
- 15 Sep 2010
- Working Paper Summaries
From Bench to Board: Gender Differences in University Scientists’ Participation in Commercial Science
- 30 Mar 2023
- Video
The Economics of Science: Turning Ideas into Applications
- 12 Aug 2020
- News
Women in Science May Suffer Lasting Career Damage from COVID-19
- 13 Jun 2017
- Blog Post
7 Reasons Why the New MS/MBA: Engineering Sciences Program at Harvard is Next Level
companies now. i.e. This is bigger than just you. Interested in learning more about the MS/MBA? Here are four things you need to know. -- Anita Mehrotra is a Class of 2018 HBS student (Section I!) and was previously a data scientist at...
View Details
- 07 Feb 2007
- Working Paper Summaries
The Value of Openness in Scientific Problem Solving
- November 2019
- Case
The Genesis Lab at Novartis
By: Amy C. Edmondson, Ranjay Gulati, Patrick J. Healy and Kerry Herman
Novartis' Genesis Labs program, launched in 2016 as part of Novartis Institutes for Biomedical Research (NIBR), hosted pitch competitions where teams of NIBR scientists proposed ideas to explore that aimed to revolutionize drug discovery. The goal was to break down...
View Details
Keywords:
Drug Discovery;
Health Care and Treatment;
Research and Development;
Innovation and Invention;
Programs;
Management
Edmondson, Amy C., Ranjay Gulati, Patrick J. Healy, and Kerry Herman. "The Genesis Lab at Novartis." Harvard Business School Case 620-007, November 2019.
- 05 Nov 2018
- News
Best Business Books 2018: Strategy
- 22 Jan 2007
- Research & Ideas
The Immigrant Technologist: Studying Technology Transfer with China
Assistant Professor William R. Kerr teaches the required first-year MBA course, The Entrepreneurial Manager, in addition to Executive Education courses at Harvard Business School. One of his core research areas is the role of immigrant entrepreneurs and View Details
Toren Fronsdal
Toren Fronsdal is a doctoral student in the Business Economics program. His research interests are industrial organization and health economics, primarily focusing on hospital and insurer negotiations. He graduated from Stanford University with a B.A. in Economics in...
View Details
- 29 Nov 2004
- Research & Ideas
Caves, Clusters, and Weak Ties: The Six Degrees World of Inventors
flows across these links—that that's the lifeblood of research and creativity. At the other extreme, we found two CEO managers in Silicon Valley who were vehemently opposed to these ideas and complained about how they hired their View Details
- 27 Feb 2013
- Research & Ideas
Sidetracked: Why Can’t We Stick to the Plan?
Why Our Decisions Get Derailed, and How We Can Stick to the Plan , behavioral scientist and HBS Associate Professor Francesca Gino explores the unexpected forces that often keep people from following through with their plans. The book,...
View Details
Keywords:
Re: Francesca Gino
- 04 Apr 2014
- News
Can Money Buy You Happiness?
- September 2009
- Case
Peter Schultz at The Scripps Research Institute
By: H. Kent Bowen, Alison Berkley Wagonfeld and Courtney Purrington
Peter Schultz, Professor of Chemistry at The Scripps Research Institute, managed an extremely productive lab. This case examines how Schultz recruited, motivated and inspired the students and scientists that worked with him.
View Details
Keywords:
Higher Education;
Factories, Labs, and Plants;
Research and Development;
Recruitment;
Selection and Staffing;
Management Style;
Motivation and Incentives;
Leadership Style
Bowen, H. Kent, Alison Berkley Wagonfeld, and Courtney Purrington. "Peter Schultz at The Scripps Research Institute." Harvard Business School Case 910-408, September 2009.
Siyu Zhang
Siyu Zhang is a second-year doctoral student at HBS. Prior to joining HBS. He was a Data Scientist at John Hancock, where he utilized machine learning models to predict the classification of insurance policy applications. Siyu is a former Investment Director at... View Details
- 04 Nov 2015
- HBS Seminar
Christian Fons-Rosen, Assistant Professor, Universitat Pompeu Fabra, Department of Economics
- June 1994 (Revised March 1995)
- Case
Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (A)
Kurt Landgraf, newly named CEO of Du Pont Merck Pharmaceutical Co., addresses complaints of discrimination from African-American scientists in R&D during significant downsizing and dramatic changes within the pharmaceutical industry.
View Details
Keywords:
Prejudice and Bias;
Race Characteristics;
Gender Characteristics;
Diversity Characteristics;
Conflict and Resolution;
Pharmaceutical Industry
Gentile, Mary C., and Sarah Gant. "Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (A)." Harvard Business School Case 394-202, June 1994. (Revised March 1995.)
- 25 Sep 2012
- Working Paper Summaries
Colocation and Scientific Collaboration: Evidence from a Field Experiment
- 14 Oct 2022
- News
Is Agenda Theater Ruining Your Meetings?
- 19 Aug 2019
- News
You 2.0: Rebel With A Cause
- 06 Mar 2020
- News